|
Volumn 36, Issue 2 SUPPL., 2004, Pages S271-S273
|
Living related liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
TACROLIMUS;
ASCITES;
BILE;
CHOLECYSTITIS;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MEGADOSE;
DRUG MONITORING;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATIC VEIN;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER GRAFT;
LIVER RESECTION;
LIVER TRANSPLANTATION;
LIVING DONOR;
LOBECTOMY;
LOW DRUG DOSE;
MICROEMULSION;
NEPHROTOXICITY;
NEUROTOXICITY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROTHROMBIN TIME;
RISK ASSESSMENT;
RISK FACTOR;
SEPSIS;
SHORT SURVEY;
|
EID: 1642367372
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.032 Document Type: Article |
Times cited : (7)
|
References (24)
|